Tandem Diabetes Care (NASDAQ:TNDM) just reported results for the second quarter of 2024.
- Tandem Diabetes Care reported earnings per share of -48 cents. This was above the analyst estimate for EPS of -54 cents.
- The company reported revenue of $221.91 million.
- This was 7.92% better than the analyst estimate for revenue of $205.63 million.